GRF — EAGLE CAPITAL GROWTH FUND, INC.

NYSE · Unknown · Unknown · CIK 850027 ·
Last close
$10.40
Market Cap
$41.27M
52W High
$10.90
52W Low
$9.86
ADV30
2,213
Next earnings
Eagle Capital Growth Fund, Inc. is a closed-end equity mutual fund launched and managed by Sims Capital Management LLC. The fund invests in the public equity markets of the United States. It makes its investments in the stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P 500 Index. It was previously known as NAIC Growth Fund, Inc. Eagle Capital Growth Fund, Inc. was formed on April 11, 1989 and is domiciled in the United States.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 47,500,636 64,690
Jun 2025
Dec 2024 45,843,132 63,108

Balance + Analyst (yfinance extras)

Retained Earnings
$23,875,611
Inventory
Receivables
$76,182
ST Investments
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$996,733
EBITDA
Free Cash Flow
Enterprise Value
Total Cash
Total Debt
$0
Shares Out
3,967,836
Trailing EPS
$1.27
Book Value
$11.96
ROE
10.8%
ROA
0.5%
Div Yield
8.17%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 5,284,764 5,028,583 47,500,636 64,690
Dec 2024 5,800,501 5,540,862 45,843,132 63,108
Dec 2023 4,853,149 4,612,434 43,002,015 64,726
Dec 2022 -1,561,908 -1,805,909 39,777,755 64,157
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
SYPR SYPRIS SOLUTIONS INC $41.45M $1.80
GAME GameSquare Holdings, Inc. $41.07M $3.16
TKRFF TINKA RESOURCES Ltd $41.47M $0.31
AACG ATA Creativity Global $40.62M $0.94
ACCL Acco Group Holdings Ltd $40.59M $2.91

News headlines (Yahoo Finance, 1h cache)

Grifols (BME:GRF) Starts Phase 3 Trials As Undervalued Narrative Faces A Fresh Test
2026-07-28 17:09 · Yahoo
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
2026-07-16 12:00 · Yahoo
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
2026-06-15 12:00 · Yahoo
Grifols (BME:GRF) Valuation Check After Mixed Short And Long Term Share Price Performance
2026-05-10 00:23 · Yahoo
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
2026-04-11 06:09 · Yahoo
Green Rise Announces Certain Management Changes
2026-01-05 22:04 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.